Artículos de interés
 
       
       
    Un servicio de APaldía
(http://www.apaldia.com)
 
       
       
    Artículos de interés publicados la semana del 30/01/2012 al 05/02/2012

PREVENCIÓN CARDIOVASCULAR
Vilsbøll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ 2012; 344: d7771-. R TC PDF
Padwal R. Glucagon-like peptide-1 agonists. BMJ 2012; 344: d7282-. R TC PDF
Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012; 344: d8059-. R TC PDF
Schmidt M, Jacobsen JB, Lash TL, Bøtker HE, Sørensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ 2012; 344: e356-. R TC PDF
Bandosz P, O'Flaherty M, Drygas W, Rutkowski M, Koziarek J, Wyrzykowski B et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ 2012; 344: d8136-. R TC PDF
Harel Z, Gilbert C, Wald R, Bell C, Perl J, Juurlink D et al. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. BMJ 2012; 344: e42-. R TC PDF
Tunstall-Pedoe H. The decline in coronary heart disease; did it fall or was it pushed?. BMJ 2012; 344: d7809-. R TC PDF
de Leeuw PW. Dual renin-angiotensin system blockade. BMJ 2012; 344: e656-. R TC PDF
Ludvigsson L, Krisky D, Casas R, Battelino T, Castaño L, Greening J et al. GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus. N Engl J Med 2012; 366: 433-442. R TC PDF
Heneghan C, Ward A, Perera R; Self-Monitoring Trialist Collaboration. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012; 379: 322-334. R TC PDF
Kyrle PA, Eichinger S. Vitamin K antagonists: self-determination by self-monitoring?. Lancet 2012; 379: 292-293. R TC PDF
Lobos Bejarano JM, Horrillo García C, González-González AI, Castellanos Rodríguez A, Díaz Sánchez S, Castellanos Maroto J et al. Validez y utilidad del péptido ventricular natriurético tipo B (BNP) en la detección de disfunción ventricular izquierda en pacientes de alto riesgo en atención primaria. Aten Primaria 2012; 44: 13-19. R TC PDF
Madridejos R. AINE y riesgo cardiovascular. Aten Primaria 2012; 44: 3-4. R TC PDF
Damman P, Wallentin L, Fox KA, Windhausen F, Hirsch A, Clayton T et al. Long-Term Cardiovascular Mortality After Procedure-Related or Spontaneous Myocardial Infarction in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II, ICTUS, and RITA-3 Tri. Circulation 2012; 125: 568-576. R TC PDF
Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DA et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations From the TRITON-TIMI 38. Circulation 2012; 125: 577-583. R TC PDF
Deo R, Albert CM. Epidemiology and Genetics of Sudden Cardiac Death. Circulation 2012; 125: 620-637. R TC PDF
Lerner EB, Rea TD, Bobrow BJ, Acker JE 3rd, Berg RA, Brooks SC et al. Emergency Medical Service Dispatch Cardiopulmonary Resuscitation Prearrival Instructions to Improve Survival From Out-of-Hospital Cardiac Arrest: A Scientific Statement From the American Heart Association. Circulation 2012; 125: 648-655. R TC PDF
Loscalzo J. Personalized Cardiovascular Medicine and Drug Development: Time for a New Paradigm. Circulation 2012; 125: 638-645. R TC PDF
Alonso Gómez AM, Comín J, Borrás X, Del Castillo S, Elvira González A, Mazón P et al. Comentarios a la guía de práctica clínica de la ESC para el tratamiento de las enfermedades cardiovasculares durante el embarazo. Una visión crítica desde la cardiología española. Rev Esp Cardiol 2012; 65: 113-118. R TC PDF
Cequier A, Carrascosa C, Diez-Tejedor E, Goicoechea M, González-García A, Quiles J et al. Comentarios a la guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología. Rev Esp Cardiol 2012; 65: 119-124. R TC PDF
Fernández-Ortiz A, Pan M, Alfonso F, Arós F, Barrabés JA, Bodí V et al. Comentarios a la guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Card. Rev Esp Cardiol 2012; 65: 125-130. R TC PDF
Gaztañaga L, Marchlinski FE, Betensky BP. Mecanismos de las arritmias cardiacas. Rev Esp Cardiol 2012; 65: 174-185. R TC PDF
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M et al. Guía de práctica clínica de la ESC para el tratamiento de las enfermedades cardiovasculares durante el embarazo. Rev Esp Cardiol 2012; 65: e1-e44. R TC PDF
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M. Guía de práctica clíníca de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas. Rev Esp Cardiol 2012; 65: e1-e57. R TC PDF
Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M. Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST. Rev Esp Cardiol 2012; 65: e1-e55. R TC PDF
Ting RD, Keech AC, Drury PL, Donoghoe MW, Hedley J, Jenkins AJ et al. Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study. Diabetes Care 2012; 35: 218-225. R TC PDF
McNeely MJ, Shofer JB, Leonetti DL, Fujimoto WY, Boyko EJ et al. Associations Among Visceral Fat, All-Cause Mortality, and Obesity-Related Mortality in Japanese Americans. Diabetes Care 2012; 35: 296-298. R TC PDF
Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of Biochemical B12 Deficiency With Metformin Therapy and Vitamin B12 Supplements: The National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care 2012; 35: 327-333. R TC PDF
Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A et al. Genetic Predictors of Weight Loss and Weight Regain After Intensive Lifestyle Modification, Metformin Treatment, or Standard Care in the Diabetes Prevention Program. Diabetes Care 2012; 35: 363-366. R TC PDF
Wheeler ML, Dunbar SA, Jaacks LM, Karmally W, Mayer-Davis EJ, Wylie-Rosett J, Yancy WS Jr. Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes: A systematic review of the literature, 2010. Diabetes Care 2012; 35: 434-445. R TC PDF
Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ. Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control. Diabetes Care 2012; 35: 446-454. R TC PDF
EDUCACIÓN SANITARIA
. Tobacco in the USA: smoke and mirrors. Lancet 2012; 379: 288-. R TC PDF
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010. JAMA 2012; 307: 483-490. R TC PDF
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010. JAMA 2012; 307: 491-497. R TC PDF
Gómez-Ambrosi J, Silva C, Catalán V, Rodríguez A, Galofré JC, Escalada J et al. Clinical Usefulness of a New Equation for Estimating Body Fat. Diabetes Care 2012; 35: 383-388. R TC PDF
PREVENCIÓN DEL CÁNCER
Andreyev HJ, Davidson SE, Gillespie C, Allum WH, Swarbrick E. Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 2012; 61: 179-192. R TC PDF
PREVENCIÓN EN EL ANCIANO
Morris J. Ensuring dignity in the care of older people. BMJ 2012; 344: e533-. R TC PDF
PREVENCIÓN EN LA INFANCIA Y LA ADOLESCENCIA
Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012; 344: d8012-. R TC PDF
Koren G, Nordeng H. SSRIs and persistent pulmonary hypertension of the newborn. BMJ 2012; 344: d7642-. R TC PDF
Diekema DS. Improving Childhood Vaccination Rates. N Engl J Med 2012; 366: 391-393. R TC PDF
Palmert MR, Dunkel L. Delayed Puberty. N Engl J Med 2012; 366: 443-453. R TC PDF
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010. JAMA 2012; 307: 483-490. R TC PDF
Goldenberg AJ, Sharp RR. The Ethical Hazards and Programmatic Challenges of Genomic Newborn Screening. JAMA 2012; 307: 461-462. R TC PDF
PREVENCIÓN EN LA MUJER
Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012; 344: d8012-. R TC PDF
Koren G, Nordeng H. SSRIs and persistent pulmonary hypertension of the newborn. BMJ 2012; 344: d7642-. R TC PDF
Alonso Gómez AM, Comín J, Borrás X, Del Castillo S, Elvira González A, Mazón P et al. Comentarios a la guía de práctica clínica de la ESC para el tratamiento de las enfermedades cardiovasculares durante el embarazo. Una visión crítica desde la cardiología española. Rev Esp Cardiol 2012; 65: 113-118. R TC PDF
Carbonell C, Díez A, Calaf J, Caloto MT, Nocea G, Lara N. Pauta de tratamiento inicial en pacientes con osteoporosis: uso de antirresortivos y suplementos farmacológicos (calcio y vitamina D) en la práctica clínica. Reumatol Clin 2012; 8: 3-9. R TC PDF
PREVENCIÓN EN SALUD MENTAL
Hatcher S, Arroll B. Newer antidepressants for the treatment of depression in adults. BMJ 2012; 344: d8300-. R TC PDF
PREVENCIÓN DE LAS ENFERMEDADES INFECCIOSAS
Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10. BMJ 2012; 344: d7901-. R TC PDF
Fauci AS, Morens MD. 200th Anniversary Article: The Perpetual Challenge of Infectious Diseases. N Engl J Med 2012; 366: 454-461. R TC PDF
Diekema DS. Improving Childhood Vaccination Rates. N Engl J Med 2012; 366: 391-393. R TC PDF

 

 
 


© 2004 PAPPS
Portaferrissa, 8 pral. 08002 Barcelona
Tel.: 93 317 03 33 / Fax: 93 317 77 72
papps@semfyc.es